Font Size: a A A
Keyword [PD-1 Inhibitors]
Result: 41 - 60 | Page: 3 of 4
41. Analysis Of The Safety And Effectiveness Of PD-1 Inhibitor Combined With Targeted Drugs Compared With Targeted Drugs Or PD-1 Inhibitor In The Treatment Of Advanced HCC
42. Efficacy And Safety Of Hepatic Arterial Infusion Chemotherapy Combined With Lenvatinib And PD-1 Inhibitors For Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
43. Association Of Lymphocyte Subsets With Efficacy And Prognosis Of PD-1 Inhibitors In Advanced Non-small Cell Lung Carcinoma
44. Study Of PD-1 Inhibitors Combined With Chemoradiotherapy/Chemotherapy In Esophageal Cancer
45. PD-1 Inhibitors Participate In The Occurrence And Development Of Myocarditis By Influencing Intestinal Flora
46. PD-1 Inhibitors Plus Chemotherapy In Recurrent Or Metastatic Nasopharyngeal Carcinoma:A Retrospective Analysis
47. Clinical Analysis Of D-TACE Combined With Microwave Ablation Followed By PD-1 Inhibitor In The Treatment Of BCLC Stage B Primary Liver Cancer
48. Effect Of PD-1 Inhibitors On Immune Metabolism Of Mito+T Lymphocytes In Patients With Non-small Cell Lung Cancer
49. Relationship Between Cytokines Levels And Efficacy Of Anti-PD-1 Immunotherapy In Non-Small Cell Lung Cancer
50. The Effect Of PD-1 Inhibitors On The Intestinal Micro-environment Of Lewis Mice And The Exploration Of Its Implications
51. Efficacy And Safety Analysis Of PD-1 Inhibitors Plus Chemotherapy In The Treatment Of Advanced Gastric Cancer
52. Analysis Of Factors Affecting The Surgical Conversion Rate Of Unresectable Hepatocellular Carcinoma With HAIC Combined With Targeted And Immunotherapy
53. Comparison Of Efficacy And Safety Of Regorafenib With Or Without PD-1 Inhibitors In The Second-line Treatment Of Advanced Hepatocellular Carcinoma
54. Prognostic Exploration Of PD-L1 Positive Circulating Tumor Cells In Advanced Hepatocellular Carcinoma Receiving Radiotherapy Combined With PD-1 Inhibitors And Targeted Drugs
55. Retrospective Analysis And Clinical Observation Of Cardiac Toxicity Related To PD-1 Inhibitors
56. Clinical Efficacy And Safety Of PD-1 Inhibitor Combined With Chemotherapy In The First-line Treatment Of Advanced Biliary Tract Malignancies
57. Analysis Of The Effectiveness And Safety Of TACE-HAIC Combined With Targeted And PD-1 Inhibitor For Intermediate And Advanced Hepatocellular Carcinoma
58. Correlation Between Circulating T Lymphocytes And PD-1 Inhibitors In The Treatment Of Advanced Non-small Cell Lung Cancer
59. Preliminary Study On The Correlation Between HMGB1 Pathway And Myocardial Injury Induced By Irradiation Combined With PD-1 Inhibitors
60. Comparative Study On The Effect Of Chemotherapy Combined With PD-1 Inhibitor And Chemotherapy Alone In Postoperative Adjuvant Therapy For Pancreatic Head Cancer
  <<First  <Prev  Next>  Last>>  Jump to